Meredith Overholt, MD
Dermatology · Knoxville, TNNPI 1801949151
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (55.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. AbbVie accounts for 78.8% of it on its own, with 27 other manufacturers making up the rest. Reporting peaked in 2023 at $7,785 and has fallen 72.3% since, to $2,157 in 2025.
Across 337 payments — averaging $63.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$17K
- Merz North America, Inc.$750
- Galderma Laboratories, L.p.$446
- Johnson & Johnson$429
- E.r. Squibb & Sons, L.L.C.$370
- LEO Pharma Inc.$327
- plus $2K from 22 others
What the payments were for
- Consulting fees$1,0005%
- Speaking & faculty fees$11,82555%
- Travel & lodging$1,5527%
- Food & beverage$6,80932%
- Education$2451%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 172 | $16,879 |
| Merz North America, Inc. | 3 | $750 |
| Galderma Laboratories, L.p. | 19 | $446 |
| Johnson & Johnson | 16 | $429 |
| E.r. Squibb & Sons, L.L.C. | 18 | $370 |
| LEO Pharma Inc. | 21 | $327 |
| Novartis | 8 | $267 |
| UCB, Inc. | 8 | $239 |
| Sun Pharmaceutical Industries Inc. | 10 | $224 |
| Arcutis Biotherapeutics, Inc. | 11 | $179 |
| Regeneron Healthcare Solutions, Inc. | 4 | $174 |
| Sanofi | 6 | $170 |
| Amgen | 9 | $165 |
| Janssen Scientific Affairs, LLC | 1 | $148 |
| Pfizer | 7 | $117 |
| Revance Therapeutics, Inc. | 2 | $108 |
| Biowound Solutions, Inc. | 2 | $73 |
| Genentech USA, Inc. | 4 | $69 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $56 |
| EPI Health, LLC | 3 | $45 |
| Incyte Corporation | 2 | $36 |
| Mayne Pharma Commercial LLC | 1 | $28 |
| Kyowa Kirin, Inc. | 1 | $26 |
| Lilly USA, LLC | 2 | $26 |
| Almirall LLC | 1 | $25 |
| Dermavant Sciences, Inc. | 1 | $23 |
| Biofrontera Inc. | 1 | $17 |
| Verrica Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$21,431 in reported general payments places this provider in the 85th percentile of 209 dermatology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OtezlaApremilast | 13 | $62,868 |
| Dupixent SyringeDupilumab | 13 | $46,469 |
| Fluorouracil | 91 | $6,150 |
| Clobetasol Propionate | 81 | $3,529 |
| Nystatin-TriamcinoloneNystatin/Triamcinolone Acet | 27 | $868 |
| Fluocinonide | 20 | $595 |
| Mupirocin | 72 | $552 |
| Triamcinolone Acetonide | 53 | $549 |
| Ketoconazole | 22 | $464 |
| Doxycycline Hyclate | 30 | $403 |
| Doxycycline Monohydrate | 24 | $345 |
| Mometasone Furoate | 21 | $312 |
| ValacyclovirValacyclovir Hcl | 22 | $266 |
| Fluconazole | 14 | $152 |
| Hydroxychloroquine Sulfate | 11 | $125 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenOtezla | $165 | $62,86813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 209 dermatology providers in Tennessee.
Other dermatology in Knoxville
- Kimberly GrandeKnoxville$224K
- Matthew DoppeltKnoxville$36K
- Carley FowlerKnoxville$27K
- Robert GriffithKnoxville$14K
- Robert GriffithKnoxville$14K
- Brittany WareKnoxville$10K
- Elizabeth AndersonKnoxville$8K
- Lee DittrichKnoxville$8K
- Kimberly VincentNashville$1.5M
- Adrian RodriguezNashville$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.